Results 211 to 220 of about 949,168 (327)
Robust deepfake detector against deep image watermarking. [PDF]
Yu J, Liu X, Zan F, Peng Y.
europepmc +1 more source
Ordinal Pooling Networks: For Preserving Information over Shrinking Feature Maps [PDF]
Ashwani Kumar
openalex +1 more source
Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky +8 more
wiley +1 more source
Feature learning augmented with sampling and heuristics (FLASH) improves model performance and biomarker identification. [PDF]
Kumar S, Agarwal A, Chatterjee S.
europepmc +1 more source
ABSTRACT Objective Status epilepticus (SE) is associated with significant mortality. Sleep architecture may reflect normal brain function. Impaired sleep architecture is associated with poorer outcomes in numerous conditions. Here we investigate the association of sleep architecture in continuous EEG (cEEG) with survival in SE.
Ran R. Liu +5 more
wiley +1 more source
Similarity-guided swarm of models: enhancing semi-supervised learning in computational pathology. [PDF]
Weng Z +9 more
europepmc +1 more source
ABSTRACT Objective People with epilepsy (PWE) may experience cognitive deficits but fail to undergo formal evaluation. This study compares cognitive status between PWE and healthy controls in the West African Republic of Guinea. Methods A cross‐sectional, case–control study was conducted in sequential recruitment phases (July 2024–July 2025) at Ignace ...
Maya L. Mastick +14 more
wiley +1 more source
Beyond accuracy: Quantifying the reliability of multiple instance learning for whole slide image classification. [PDF]
Keshvarikhojasteh H +4 more
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Dual chain dynamic hypergraph convolution network for 3D human pose estimation. [PDF]
Han Q, Zhang S, Wang P.
europepmc +1 more source

